Patent · US Expired

Thoracic impedance detection with blood resistivity compensation

US7387610B2 · kind B2 · utility

159Cited by
142References
83Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 19, 2004
Grant dateJun 17, 2008
Priority date
Expiry dateNov 4, 2025

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/36521
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

This document discusses, among other things, a cardiac rhythm management device or other implantable medical device that uses thoracic impedance to determine how much fluid is present in the thorax, such as for detecting or predicting congestive heart failure, pulmonary edema, pleural effusion, hypotension, or the like. The thoracic fluid amount determined from the thoracic impedance is compensated for changes in blood resistivity, which may result from changes in hematocrit level or other factors. The blood-resistivity-compensated thoracic fluid amount can be stored in the device or transmitted to an external device for storage or display. The blood-resistivity-compensated thoracic fluid amount can also be used to adjust a cardiac pacing, cardiac resynchronization, or other cardiac rhythm management or other therapy to the patient. This document also discusses applications of the devices and methods for predicting or indicating anemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.